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Crossing the fi nish line 
With clinical trials complete, private funds are needed to gain 
FDA approval for human islet transplants
Pastor Constance “Connie” Olson worked 70-hour weeks, tending to the needs—spiritual and 
otherwise—of her congregation. She was also a type 1 diabetic, suff ering from hypoglycemic 
unawareness. This complication meant that she didn’t experience early warning signs of dangerously 
low blood sugar—such as sweating, dizziness, and extreme hunger—causing her to unexpectedly have 
seizures and lose consciousness. 
“I was very rigid in my care,” Olson says. “I tested my blood 
sugar 12 times a day. I never drove without testing. And I 
was afraid to leave the house without my glucose tablets or 
monitor. I loved my work, and it was really hard for me to 
admit that I wasn’t feeling well.” 
Olson applied to and was eventually accepted into the 
University of Minnesota’s human-to-human islet cell 
transplantation clinical trial—her best hope of a cure.
A er undergoing two islet transplants, she is now free from 
the daily burden of diabetes.
The clinical trial that Olson participated in is now complete 
and boasting impressive results. And the University is 
positioned to become one of the fi rst centers in the country 
to off er human islet transplantation as a routine medical 
procedure for qualifi ed adults. The fi nal step needed to bring 
these transplants to more patients is the estimated $5 million 
funding required to obtain a biologic license from the U.S. 
Food and Drug Administration (FDA) to procure islets from 
donor pancreases for transplantation.
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Discoveries in Diabetes
When Connie Olson was diagnosed with 
type 1 diabetes at age 17, her mother told 
her she wouldn’t live to age 50. “Now, I’m 62, 
and I can look ahead,” says Olson, a human 
islet transplant recipient, pictured with her 
husband, David.
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IRA charitable giving opportunity extended for 2013
Thanks to recent legislation, you can benefi t from a popular tax-advantaged 
giving option again this year.
You can make a gi  of up to $100,000 directly from your IRA to the 
University of Minnesota Foundation to support diabetes research at the 
University of Minnesota before December 31, 2013, and avoid paying federal 
income tax on the amount of your gi .  
To learn more, visit h p://z.umn.edu/ira2013 or contact Jean Gorell 
at 612-625-0497 or jgorell@umn.edu.
Register now!
Golf Classic “Fore” Diabetes Research
June 17, 2013
Town and Country Club, St. Paul, Minn.
Join us for a day of golf, food, 
and fun at the 17th annual 
Golf Classic “Fore” 
Diabetes Research, 
which has raised nearly 
$5 million to advance 
a cure for diabetes at 
the University’s Schulze 
Diabetes Institute. The 
tournament includes 
morning and a ernoon 
rounds, an exceptional live 
auction, and a lunch and 
dinner program.
Visit h p://z.umn.edu/golfclassic 
to register.             
Join us for a special event: Never a vacation!    
Because there is never a vacation from caring for one’s diabetes.
12:30 p.m., Sunday, June 23, 2013, Interlachen Country Club, Edina, Minn.
Enjoy a luncheon and style show featuring adult and children’s clothing 
from designers and retailers. Proceeds support the University’s diabetes 
immunology research led by Brian Fife, Ph.D.
Adults: $100, Children: $25
For tickets or more information, contact Ellie Cadmus at 612-920-7243.
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U of M: A leader in human islet 
transplantation
The transplantation of islets from a donor 
pancreas into a diabetic patient has been studied 
since the 1970s. In fact, the fi rst transplant of 
its kind to treat type 1 diabetes occurred at the 
University in 1974. Numerous studies and clinical 
trials have followed, with tremendous progress in 
recent years. 
In 2004, the University was selected as one of 
three principal sites to conduct phase III clinical 
trials in human islet transplants—a $100 million, 
multicenter trial supported by the National 
Institutes of Health. The clinical trial was a 
success for patients like Olson and many others, 
giving them lives free from diabetes.
“No other center has enrolled more patients 
than the U of M,” says Bernhard Hering, M.D., 
scientifi c director of the University’s Schulze 
Diabetes Institute. “The U of M has been a 
major contributor to this study at several levels.”
The best results
Today, the U’s clinical trials are delivering the 
world’s best results: all transplant recipients were 
protected from hypoglycemia immediately a er 
the transplant, 80 percent remained protected 
from severe hypoglycemia for fi ve years post-
transplant, 90 percent have become insulin 
independent, and more than 50 percent have 
maintained insulin independence for fi ve years 
post-transplant.
“It is fair to say that both the effi  cacy and safety 
results are very favorable and clearly document 
the feasibility of the human islet transplants in 
helping and treating people with type 1 diabetes 
complicated by hypoglycemic unawareness,” 
Hering says.
He emphasizes how miserable life can be for 
those with hypoglycemic unawareness, recalling 
stories of patients who have lost jobs, homes, 
and marriages. But a er receiving the islet 
transplant, patients seem to get a second chance 
at a normal life. 
“With islet transplantation, people now, for 
the very fi rst time, can enjoy a life no longer 
restricted by constant fears and worries. We 
consider this a privilege, being able to participate 
in this life-changing research,” Hering says.
Funding still needed 
With decades of research complete, the 
University has one more step: securing a 
biologic license from the FDA to procure islets 
from donor pancreases for transplantation, a 
process that will require about $5 million.
A lead gi  of $50,000 from Wally and Cecy 
Faster in January of this year will help the 
University on its way to raising the funds needed 
to become the fi rst U.S. clinic to transplant 
human islets as an approved medical procedure. 
Once licensed, the University will off er patients 
greater access to islet transplantation and 
will use this treatment as the platform for 
continuing to develop the next-generation of 
transplantation cures, including the use of 
pig and stem cell islets, with minimal or no 
antirejection drugs.
Today Olson is busy spreading the gospel of 
islet transplantation, speaking to groups about 
the transformational procedure. “It’s one way for 
me to contribute,” she says, “to say thank you 
and to help make future transplants possible, 
especially for children.”
Crossing the fi nish line  (continued from cover) 
Siobhan O’Brien Olson grew up understanding 
the importance of community giving. In fact, 
her family’s Alice M. O’Brien Foundation 
has been supporting numerous charities in 
Minnesota for 60 years. Nearly eight years 
ago, the foundation established the O’Brien 
BioBank for lung research at the University 
of Minnesota—just one of numerous gi s the 
foundation has made to support medical 
research at the University.
But it is the foundation’s latest gi  of $15,000 
to support diabetes research at the University 
that’s top of mind for O’Brien Olson and her 
husband, Dave Olson. “Diabetes aff ects every 
side of our family in some way, shape, or form,” 
says O’Brien Olson. “When we heard about the 
artifi cial pancreas project [featured in the last 
issue of Discoveries in Diabetes], we thought it 
could really be a game-changer.”
Diagnosed at age 17 with type 1 diabetes, 
Dave Olson appreciates the project’s research 
potential. A few years ago, when adding a 
continuous glucose monitoring system to his 
insulin pump, he asked how the system and 
the pump communicate and was surprised 
to learn that the pump did not take in that 
glucose information to automatically adjust 
the insulin dose.
That could all change with the creation of an 
artifi cial pancreas that uses a wireless sensor 
being developed by Steven Koester, Ph.D., 
a professor in the University’s electrical 
engineering department. The monitor, which 
is still in the design phase, senses glucose 
levels and sends that information to the pump, 
which automatically supplies the correct 
amount of insulin. 
A call for proposals from the Minnesota 
Partnership for Biotechnology and Medical 
Genomics—a collaboration of the University 
and Mayo Clinic—sparked Koester’s search for 
potential research partners at Mayo. There he 
found Yogish Kudva, M.B.B.S., and Ananda Basu, 
M.B.B.S., M.D., who were building an artifi cial 
pancreas but had run into sensor issues. 
“In talking together,” Koester says, “we realized 
they had a sensor problem my idea could 
potentially solve.” Since then, the trio has 
made impressive progress, but they have more 
work ahead and need additional support. 
This project is buoyed by the Minnesota 
Partnership for Biotechnology and Medical 
Genomics’ statewide campaign to prevent, treat, 
and cure diabetes—called Decade of Discovery. 
But Koester says that private philanthropy 
remains critical, and he’s grateful for the 
generosity of donors like the Alice M. O’Brien 
Foundation, “It’s vital to sustain this project as 
we gather data and write proposals,” he adds.
The Olsons hope the breakthrough comes 
soon. “It seems like a natural next step, and 
I think they’re very close,” says Dave Olson. 
“This technology will go a long way toward 
substantially improving the lives of those 
of us who live each day with diabetes. It 
is a very exciting and real step forward in 
diabetes management.”
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